AGITATION IN DEMENTIA

Clinical trials for AGITATION IN DEMENTIA explained in plain language.

Never miss a new study

Get alerted when new AGITATION IN DEMENTIA trials appear

Sign up with your email to follow new studies for AGITATION IN DEMENTIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a cannabis drug soothe Alzheimer's agitation? new trial aims to find out.

Symptom relief Not yet recruiting

This study tests whether dronabinol, a cannabis-based oral solution, can reduce agitation in people with Alzheimer's disease. About 140 adults aged 50-90 will receive either the drug or a placebo for 12 weeks, followed by a 6-month period where everyone gets dronabinol. The goal …

Matched conditions: AGITATION IN DEMENTIA

Phase: PHASE2, PHASE3 • Sponsor: Benuvia Therapeutics Inc. • Aim: Symptom relief

Last updated May 04, 2026 05:18 UTC

AGITATION IN DEMENTIA

Get alerted when new AGITATION IN DEMENTIA trials appear

Can a cannabis drug soothe Alzheimer's agitation? new trial aims to find out.